Borger, D. R., Goyal, L., Yau, T., Poon, R. T., Ancukiewicz, M., Deshpande, V., . . . Zhu, A. X. (2014). Circulating oncometabolite 2-hydroxyglutarate is a potential surrogate biomarker in patients with isocitrate dehydrogenase-mutant intrahepatic cholangiocarcinoma. Clinical cancer research, 20(7), 1884. https://doi.org/10.1158/1078-0432.CCR-13-2649
Citace podle Chicago (17th ed.)Borger, Darrell R., et al. "Circulating Oncometabolite 2-hydroxyglutarate Is a Potential Surrogate Biomarker in Patients with Isocitrate Dehydrogenase-mutant Intrahepatic Cholangiocarcinoma." Clinical Cancer Research 20, no. 7 (2014): 1884. https://doi.org/10.1158/1078-0432.CCR-13-2649.
Citace podle MLA (9th ed.)Borger, Darrell R., et al. "Circulating Oncometabolite 2-hydroxyglutarate Is a Potential Surrogate Biomarker in Patients with Isocitrate Dehydrogenase-mutant Intrahepatic Cholangiocarcinoma." Clinical Cancer Research, vol. 20, no. 7, 2014, p. 1884, https://doi.org/10.1158/1078-0432.CCR-13-2649.